Deferasirox in Indian children with thalassemia major: 3 years experience
Objective: To evaluate the efficacy and safety of the oral iron chelator deferasirox in treating transfusional hemosiderosis in a cohort of Indian children with thalassemia major with high iron load. Materials and Methods: The first 50 children (age 2-18 yrs) with thalassemia major to commence defer...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2013-01-01
|
| Rangatū: | Indian Journal of Medical and Paediatric Oncology |
| Ngā marau: | |
| Urunga tuihono: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=1;spage=16;epage=20;aulast=Dhamija |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|